MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition
about
Pancreatic cancer stem cell markers and exosomes - the incentive pushCancer stem cells (CSCs), cervical CSCs and targeted therapiesRegulation of Metastasis by microRNAs in Ovarian CancerImpact of Nutrition on Non-Coding RNA Epigenetics in Breast and Gynecological CancerMicroRNA and Long Non-Coding RNA in Ovarian Carcinoma: Translational Insights and Potential Clinical Applications.The role of microRNAs in ovarian cancerCD117 expression in fibroblasts-like stromal cells indicates unfavorable clinical outcomes in ovarian carcinoma patients.Culture medium of bone marrow-derived human mesenchymal stem cells effects lymphatic endothelial cells and tumor lymph vessel formation.Downregulated lincRNA HOTAIR expression in ovarian cancer stem cells decreases its tumorgeniesis and metastasis by inhibiting epithelial-mesenchymal transitionCD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition.Combining TGF-β1 knockdown and miR200c administration to optimize antitumor efficacy of B16F10/GPI-IL-21 vaccine.MicroRNA-17-5p induces drug resistance and invasion of ovarian carcinoma cells by targeting PTEN signaling.Effect of targeted ovarian cancer immunotherapy using ovarian cancer stem cell vaccine.Cancer stem cell vaccine expressing ESAT-6-gpi and IL-21 inhibits melanoma growth and metastasesTarget therapy of multiple myeloma by PTX-NPs and ABCG2 antibody in a mouse xenograft modelInhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cellsmiR-203 Functions as a Tumor Suppressor by Inhibiting Epithelial to Mesenchymal Transition in Ovarian CancermiR-200c inhibits breast cancer proliferation by targeting KRASDecreasing lncRNA HOTAIR expression inhibits human colorectal cancer stem cellsmiR-494 inhibits ovarian cancer cell proliferation and promotes apoptosis by targeting FGFR2.Serum miR-200c and clinical outcome of patients with advanced esophageal squamous cancer receiving platinum-based chemotherapy.Gene therapy of ovarian cancer using IL-21-secreting human umbilical cord mesenchymal stem cells in nude mice.MiRNA-34a overexpression inhibits multiple myeloma cancer stem cell growth in mice by suppressing TGIF2.Epithelial-mesenchymal transition of ovarian cancer cells is sustained by Rac1 through simultaneous activation of MEK1/2 and Src signaling pathways.Regulation gene expression of miR200c and ZEB1 positively enhances effect of tumor vaccine B16F10/GPI-IL-21 on inhibition of melanoma growth and metastasisMicroRNA control of epithelial-mesenchymal transition in cancer stem cells.Restoring TRAIL mediated signaling in ovarian cancer cells.Role of epithelial to mesenchymal transition proteins in gynecological cancers: pathological and therapeutic perspectives.Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.miRNAs as prognostic and therapeutic tools in epithelial ovarian cancer.MicroRNAs associated with the efficacy of photodynamic therapy in biliary tract cancer cell lines.miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway.Current status on microRNAs as biomarkers for ovarian cancer.EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN.Effect of downregulation of ZEB1 on vimentin expression, tumour migration and tumourigenicity of melanoma B16F10 cells and CSCs.MicroRNAs in gynecological cancers: Small molecules with big implications.Updates and current challenges in microRNA research for personalized medicine in ovarian cancer.MiR-200c regulates tumor growth and chemosensitivity to cisplatin in osteosarcoma by targeting AKT2Potential microRNA-related Targets for Therapeutic Intervention with Ovarian Cancer Metastasis.Three-Dimensional Cellular Arrangement in Epithelial Ovarian Cancer Cell Lines TOV-21G and SKOV-3 is Associated with Apoptosis-Related miRNA Expression Modulation.
P2860
Q26741215-FA8A3C00-C3C6-4704-94F3-BD084DC85B0EQ26747144-77F077AF-CDAB-46C5-9B5D-23D5991B646FQ26997006-4CDFCB0C-EF04-4306-9CB9-EABBD0D8CE2DQ27016123-B0705590-5CA5-45F7-831F-BDD5F3D619ACQ30244282-622E31FD-3367-4F17-9E39-32242E45D5FFQ34253436-9D45163D-B678-470F-829C-1D2BC33889BCQ34473048-1E2331FB-C3D5-43D2-8E5D-302AEDE48474Q35042182-472375A5-2F6B-4D38-AE61-4E11ED3B14B3Q35194042-EEED01E4-D855-4941-B5DD-C8B51D515A2DQ35742418-8DD4E1CA-BB76-46D3-9BC9-98780C5F651FQ35828614-8D3E83C6-5C49-4B28-9297-C0894B03C8E4Q36202394-C65C7EFD-9F73-4712-A101-F6ECDEC11786Q36204651-C6434D65-3E15-4C63-AEEE-444C9D75E5EEQ36309496-FB42DC0C-5848-4AE5-A179-C8B062C9BC0AQ36413883-EB1947E0-7FBA-4328-A410-2B481B162C3AQ36419610-4E953EC0-8E8E-436D-806F-0F8A21E9152DQ36497625-A8D528D3-0D1E-435C-BD34-D995C02DA2B4Q36544271-B6EB28C7-2FAC-4C44-893D-5444434BD2E9Q36595097-78409E11-6A6D-4102-93B7-8E54E4E511A8Q36954415-8D3F97D5-367A-4046-BBE9-4F0055471EF3Q37369075-BFF5C61E-0FA2-4BAE-8863-BF557D336D1CQ37539525-2A5BF7B9-2900-43FD-9BFC-A5A9F2E7D59AQ37553776-0A6BCDBF-E303-4B04-B015-EDDD30713595Q37694339-8D08047E-4222-4E58-8B20-F63EAB60686EQ37716594-F139351B-FC24-4A90-93D1-3295417ADDE7Q38185615-41D397BE-55A0-4D05-B2F0-959E9A479C04Q38230205-5A79B0C8-A755-4D68-8666-02D1F5C9B3A5Q38244309-35A9DCDF-9260-4648-97B0-536ADAC4173AQ38258014-77FA0873-133D-4F85-BB7B-471C0A2772A6Q38366731-0936705E-6BCB-43B8-B11B-5BC9FC871EF2Q38470678-0D82E572-0C6B-49D6-91B0-9304078569D2Q38705370-0FC9245F-7E74-4696-B8BD-E82E9488F852Q38711390-5CD72E54-9FB5-4947-98C5-80CD735234A5Q38944897-E1B0F4A6-1997-4F91-8DD2-E95F134D01C7Q39043081-3BCACA17-577A-400D-9324-4416CE5AD370Q39333266-3DF10D92-B867-4ECC-9FA5-E0994C4AE4E8Q39391417-2995F597-4EBE-4FBD-BB0C-C4DAC9EC074AQ42659697-75DE148E-9AC4-4203-9654-90AE087A9BD1Q49593669-8A09B05D-C012-4F5D-953D-F8FCB129CE0CQ50147073-3890C480-9E9C-474C-8ACD-73CAA61ADC14
P2860
MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNA-200c overexpression i ...... thelial-mesenchymal transition
@en
MicroRNA-200c overexpression i ...... helial-mesenchymal transition.
@nl
type
label
MicroRNA-200c overexpression i ...... thelial-mesenchymal transition
@en
MicroRNA-200c overexpression i ...... helial-mesenchymal transition.
@nl
prefLabel
MicroRNA-200c overexpression i ...... thelial-mesenchymal transition
@en
MicroRNA-200c overexpression i ...... helial-mesenchymal transition.
@nl
P2093
P2860
P356
P1476
MicroRNA-200c overexpression i ...... thelial-mesenchymal transition
@en
P2093
Cuiping Yang
Dengyu Chen
Fangfang Shi
Junsong Chen
Xiaoying Wang
Yunxia Zhang
P2860
P2888
P356
10.1186/1757-2215-6-50
P577
2013-07-10T00:00:00Z
P5875
P6179
1005067324